Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
about
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaInduction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinomaAdvanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesAn update on larynx cancerEpidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinomaSurvival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerAdvances in the management of squamous cell carcinoma of the head and neck.Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatmentPhase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature.Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapyChemotherapy advances in locally advanced head and neck cancerChemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerHelical tomotherapy in head and neck cancer: a European single-center experience.DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancerNab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neckInduction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 studyInduction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.Sequential chemoradiation in locally advanced head and neck cancer after induction chemotherapy: an induction chemotherapy schedule more suited to a limited resource settingThe Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancerLong-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma.Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathwaysInduction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservationChemotherapy: United Kingdom National Multidisciplinary GuidelinesIntensity-modulated radiotherapy in the treatment of locoregionally advanced head and neck cancer: implementation and outcomes in a New Zealand community hospital.Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapyOutcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.
P2860
Q24200362-714E1A6E-56B3-45BD-A4D6-CB59A45AD64DQ24200903-310ECD79-06B3-4139-82F0-81983584D718Q26767046-9F9DD96A-CE09-48D2-AC3C-14320F9BBE62Q28079132-A39808C2-4BFC-49F7-B2B0-B0124CE6F524Q28543724-BCC849C9-1C87-4347-871D-5397141F4CECQ31057366-C66EE35A-C81D-4BFF-9892-F1E68AC1BAE9Q31136094-8F5E3521-7C6C-467D-B792-43C61E1D86A4Q33420293-A255DF40-025A-4109-BDCA-6B5F8AC20505Q33426763-322AF258-5ECA-493A-9463-899C4A2054BFQ33711438-E8634BEF-4004-4EAC-8EC2-0763E9378898Q33720431-46A62BBD-E1DA-4135-A6A0-E3ABFF1520C4Q33725229-1EAC1B74-2F85-417C-A9B9-27CE8779F0EBQ33858049-CF7AD7AC-F8BC-48AC-BBF4-C6D732F4C664Q33886353-E974529C-0680-4B5B-8486-3CC8617221FCQ33943031-5238C15B-CF5A-4887-B1C1-6A4431BBBEEBQ34369298-86EA7A0D-B0BC-4BC5-BA9F-2150A0C9201FQ34407889-EAB011FF-C199-447C-BB67-0E35B4F698CBQ34430205-863A518E-A679-4C14-96F8-DE373763485DQ34610984-F73F1CE6-52D8-4392-AAC1-634C0A6D8374Q34657763-51FBEF96-AA9A-4255-9D31-67F3E569E02DQ34691622-A82F6395-F6AC-4D25-8FD3-CE5B0254B7DCQ35151101-00C64435-756F-4639-B80D-56E88A222B8CQ35206363-89BB4F78-14B1-447A-9F39-9D3DC2105413Q35469234-A56141B9-45A2-4645-BA72-9B52965E175FQ35602143-AF0CB0F2-4973-4D2A-8FD1-8E11C54F87C2Q35652246-BB22F07C-AFA8-44BB-A88E-077FF15928BEQ35717521-EB49C4EA-BF91-451A-88BE-D857FD29EBE4Q35845864-E791C617-F494-481B-A8AD-EF34D9033CE5Q36172019-BE0F91E9-435C-4818-A281-2710DE8E829CQ36210999-F98FE64E-DE85-4029-AE30-9FC0C6D6A0E4Q36341166-958161CF-D690-4E02-8235-C4583F056FFDQ36447729-7197B836-9BDC-482B-A598-F5DD6B9CA6BAQ36452263-0BA2BC52-73BA-49C3-A0A0-C0F2FBF9DA4EQ36482404-4481F43E-0526-42FF-A1AC-7C3D7049F96BQ36546515-C76FCED9-B867-4BD2-837E-DC3BACE92360Q36864470-82ADF255-BB76-4B74-A7F6-52BB31360505Q36919595-5BC5EA01-2205-4337-9FDA-ABE663C6BB73Q37023648-BDDD6BBC-6B36-45EC-BC8A-198E5D068B52Q37123625-BF7693DD-7003-41E8-9336-69669678DACAQ37206229-D9397183-7072-4CC9-AD73-D5951BF3904D
P2860
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@ast
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@en
Induction chemotherapy followed by concurrent chemoradiotherapy
@nl
type
label
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@ast
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@en
Induction chemotherapy followed by concurrent chemoradiotherapy
@nl
prefLabel
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@ast
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@en
Induction chemotherapy followed by concurrent chemoradiotherapy
@nl
P2093
P921
P1433
P1476
Induction chemotherapy followe ...... ): a randomised phase 3 trial.
@en
P2093
Anne O'Neill
Douglas Adkins
Fadlo Khuri
Guilherme Rabinowits
Jochen Lorch
Jonathan J Beitler
Joseph Clark
Marshall Posner
Nicholas Sarlis
Robert Haddad
P304
P356
10.1016/S1470-2045(13)70011-1
P577
2013-02-13T00:00:00Z